Frank T. Cannone is the Chair of the Corporate Department and a member of the Executive Committee at Gibbons P.C. Mr. Cannone’s practice is focused on mergers and acquisitions, private equity, early-stage and emerging growth, and corporate and securities law.
He has extensive experience representing clients in connection with public and private capital raising, private equity, venture capital, mergers and acquisitions (in middle market transactions), public-private-partnerships (P3)/government transactions, alternative energy finance, corporate healthcare, venture capital transactions, and cross border transactions.
Under Mr. Cannone’s leadership, the Gibbons Corporate Department has become known for its complex and sophisticated transactions and strong capital markets- based approach to corporate practice, which makes it unique among New Jersey headquartered firms.
As a result, the Gibbons Corporate Department in 2013 earned positions on the DOW JONES Private Equity Analyst lists of “Most Active Law Firms” in the nation in private equity transactions for the sixth year in a row.
In addition, the National Law Journal placed Gibbons on its prestigious “Midsize Hot List” of just 20 leading mid-sized law firms in the United States, due in part to the Corporate Department’s experience in handling “major transactions for midmarket companies and middle market deals for major companies.” The Corporate Department has also been ranked and recognized by Chambers USA as a leading force in the corporate arena.
Mr. Cannone has led the expansion of the Corporate Department’s services and value-added offerings to become one of the region’s top corporate practices. Of particular note, following the passage of the historic New Jersey Medical and Health Sciences Restructuring Act, which mandated the re-allocation of New Jersey medical educational institutions and facilities among several existing New Jersey institutions of higher education, Gibbons served as a key player in connection with the implementation of the Restructuring Act in 2013.
Mr. Cannone and his team served as lead counsel to Rowan University, which, under the Restructuring Act, was allocated the School of Osteopathic Medicine (among other assets), divested from the University of Medicine and Dentistry of New Jersey. The divesture is viewed as a one of the largest and most complex higher education merger in United States history and was recognized by The Bond Buyer for its prestigious and nationally recognized Health Care Deal of the Year for 2013.
Mr. Cannone is also:
- A member of the Board of Visitors (Board of Trustees) for the Seton Hall University School of Law.
- A member of the Board of Advisors for the Seton Hall University Stillman School Center for Entrepreneurial Studies.
- A member of the Executive Committee of the New Jersey Italy Trade Council.
- A member of the Association for Corporate Growth, including the ACG Transactional Counsel and CEOs Roundtables.
- A member of NAREIT and Project Finance Editorial Advisory Board Member, Law360.
- A member of the New Jersey and New York Bars and a graduate with honors of Boston College and Seton Hall University School of Law.
- Seton Hall University School of Law (J.D., cum laude)
- Managing Editor, Seton Hall Law Review, 1990-1991
- Boston College (B.S., magna cum laude)
- State of New Jersey
- State of New York
- New Jersey State Bar Association
- Renewable Energy, Cleantech, and Climate Change Special Committee
- New York State Bar Association
- Seton Hall University Stillman School Center for Entrepreneurial Studies
- Board of Advisors
- New Jersey Symphony Orchestra
- Board of Trustees
- Seton Hall University School of Law
- Board of Visitors
- New Jersey Italy Trade Council
- Executive Committee
- Association of Corporate Growth (ACG) and the ACG CEO Roundtable
Rate : $$$